You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for New Drug Application (NDA): 220518

✉ Email this page to a colleague

« Back to Dashboard

NDA 220518 describes MESNA, which is a drug marketed by Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Mylan Institutional, Rising, Sagent Pharms Inc, Teva Pharms Usa, and Novast Labs, and is included in nine NDAs. It is available from six suppliers. Additional details are available on the MESNA profile page.

The generic ingredient in MESNA is mesna. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the mesna profile page.

Summary for 220518

Tradename:	MESNA
Applicant:	Eugia Pharma
Ingredient:	mesna
Patents:	0

Pharmacology for NDA: 220518

Medical Subject Heading (MeSH) Categories for 220518

Protective Agents

Suppliers and Packaging for NDA: 220518

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MESNA	mesna	INJECTABLE;INTRAVENOUS	220518	ANDA	Eugia US LLC	55150-520	55150-520-01	1 VIAL, MULTI-DOSE in 1 BOX (55150-520-01) / 10 mL in 1 VIAL, MULTI-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INTRAVENOUS			Strength	100MG/ML
Approval Date:	Jan 27, 2026	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.